Table 3.
Treatments in elderly patients with COVID-19
| Total | Survivor | Non-survivor | P* | |
|---|---|---|---|---|
| n = 147 (%) | n = 105 (%) | n = 42 (%) | ||
| Antivirals | 143 (97.3) | 104 (99.1) | 39 (92.9) | 0.071 |
| Antibiotics | 124 (84.4) | 82 (78.1) | 42 (100.0) | < 0.001 |
| Hormone | 70 (47.6) | 42 (40.0) | 28 (66.7) | 0.006 |
| Gamma globulin | 66 (44.9) | 43 (41.0) | 23 (54.8) | 0.145 |
| Chinese medicine | 108 (73.5) | 81 (77.1) | 27 (64.3) | 0.147 |
| Oxygen | 132 (89.8) | 91 (86.7) | 41 (97.6) | 0.068 |
| Vasoactive drugs | 32 (21.8) | 3 (2.9) | 29 (69.1) | < 0.001 |
| Hemodialysis | 4 (2.7) | 3 (2.9) | 1 (2.4) | 0.999 |
| Other therapy | 95 (64.6) | 64 (61.0) | 31 (73.8) | 0.182 |
*P values were calculated by the Chi-square test for categorical variables, and the Fisher’s exact test was used when the data were limited. *P < 0.05